Number of patients studied prior to approval of new medicines: a database analysis
about
Systematic reviews to ascertain the safety of diabetes medicationsA new approach to psychiatric drug approval in EuropeTorsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across EuropePremarket safety and efficacy studies for ADHD medications in childrenData informs debatePivotal clinical trials of novel ophthalmic drugs and medical devices: retrospective observational study, 2002-2012Protections for clinical trials in low and middle income countries need strengthening not weakeningRegulatory anticipation of postmarket safety problems for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional study.Evaluation of Pre-marketing Factors to Predict Post-marketing Boxed Warnings and Safety Withdrawals.Benefit-risk reassessment of medicines: a retrospective analysis of all safety-related referral procedures in Europe during 2001-2012.Characteristics and follow-up of postmarketing studies of conditionally authorized medicines in the EU.Risk Perceptions in Diabetic Patients Who Have Experienced Adverse Events: Implications for Patient Involvement in Regulatory Decisions.Post-approval safety issues with innovative drugs: a European cohort study.Is patient exposure preapproval and postapproval a determinant of the timing and frequency of occurrence of safety issues?Post-marketing research and its outcome for novel anticancer agents approved by both the FDA and EMA between 2005 and 2010: A cross-sectional study.E-health data to support and enhance randomised controlled trials in the United Kingdom
P2860
Q27000766-FAFADFCF-6572-47F4-B8E0-7931B408DF1BQ28534418-B2DE147C-264E-4A9F-BEF6-F896328BA7C5Q28535299-16684023-7F3A-44B9-B2CD-C6D215DA9171Q28540563-752B3645-510C-419D-A49C-2B6C9AF93D9EQ31031028-235D5092-35AB-4990-961D-0C9B30C33032Q35691857-DCF7CCCF-198A-4813-9AB5-14C9D0F59D58Q36396604-EC6F1C9A-BD3A-4856-8B82-B1A9C80A03AAQ38629594-EEB1A140-36B8-4458-B92F-30AB31628C4DQ38877083-B1F7E519-D52C-4991-A258-823C3F317CCFQ39794630-F8C89B30-83C9-4FC7-9E2A-D3B1CD430BB3Q39908428-F404B578-9F1F-4E27-8528-D76EF8B65259Q41204304-079B5120-5CE9-4321-9316-141654DBC2CCQ45022481-38C730F2-AFF5-4739-8FBD-90895155F21DQ48347862-5E6A599C-010A-481B-B085-4B20023D2DCBQ50001044-FD0614A2-2BB7-45C0-BD2C-2490681CC376Q57519006-6F9B1B73-AF9B-4A03-8BF1-851CA93D6166
P2860
Number of patients studied prior to approval of new medicines: a database analysis
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Number of patients studied prior to approval of new medicines: a database analysis
@ast
Number of patients studied prior to approval of new medicines: a database analysis
@en
Number of patients studied prior to approval of new medicines: a database analysis
@nl
type
label
Number of patients studied prior to approval of new medicines: a database analysis
@ast
Number of patients studied prior to approval of new medicines: a database analysis
@en
Number of patients studied prior to approval of new medicines: a database analysis
@nl
prefLabel
Number of patients studied prior to approval of new medicines: a database analysis
@ast
Number of patients studied prior to approval of new medicines: a database analysis
@en
Number of patients studied prior to approval of new medicines: a database analysis
@nl
P2093
P2860
P1433
P1476
Number of patients studied prior to approval of new medicines: a database analysis
@en
P2093
Anthonius de Boer
Arno W Hoes
June M Raine
Sabine M J M Straus
P2860
P304
P356
10.1371/JOURNAL.PMED.1001407
P407
P577
2013-03-19T00:00:00Z